Novavax Inc logo

Novavax Inc

14
1
NAS:NVAX (USA)   Ordinary Shares
$ 4.09 +0.1 (+2.52%) 10:08 PM EST
At Loss
Market Cap:
$ 572.41M
Enterprise V:
$ 216.19M
Volume:
1.85M
Avg Vol (2M):
7.76M
Also Trade In:
Volume:
1.85M
At Loss
Avg Vol (2M):
7.76M

Business Description

Novavax Inc logo
Novavax Inc
NAICS : 325414 SIC : 2836
ISIN : US6700024010

Share Class Description:

NVAX: Ordinary Shares
Description
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.
Name Current Vs Industry Vs History
Cash-To-Debt 2.48
Equity-to-Asset -0.4
Debt-to-Equity -0.32
Debt-to-EBITDA -0.47
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -4.53
Distress
Grey
Safe
Beneish M-Score 4.47
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 26.89
9-Day RSI 27.15
14-Day RSI 33.79
6-1 Month Momentum % -26.91
12-1 Month Momentum % -45.85

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.7
Quick Ratio 0.67
Cash Ratio 0.35
Days Inventory 43.67
Days Sales Outstanding 106.43
Days Payable 140.81

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -25.3
Shareholder Yield % -18.6

Financials (Next Earnings Date:2024-05-09 Est.)

NVAX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:NVAX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Novavax Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 693.461
EPS (TTM) ($) -5.56
Beta 1.87
Volatility % 51.34
14-Day RSI 33.79
14-Day ATR ($) 0.255714
20-Day SMA ($) 4.39925
12-1 Month Momentum % -45.85
52-Week Range ($) 3.5324 - 11.36
Shares Outstanding (Mil) 139.95

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Novavax Inc Filings

Filing Date Document Date Form
No Filing Data

Novavax Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Novavax Inc Frequently Asked Questions

What is Novavax Inc(NVAX)'s stock price today?
The current price of NVAX is $4.09. The 52 week high of NVAX is $11.36 and 52 week low is $3.53.
When is next earnings date of Novavax Inc(NVAX)?
The next earnings date of Novavax Inc(NVAX) is 2024-05-09 Est..
Does Novavax Inc(NVAX) pay dividends? If so, how much?
Novavax Inc(NVAX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1